Talking Tumors: Treating With Immunotherapy and Targeted Therapy in Lung Cancer

We recently traveled to Chicago, Illinois, for a State of the Science Summit™ on Lung Cancer. Jyoti D. Patel, MD, and Lawrence E. Feldman, MD, discuss second-line therapy in extensive-stage small cell lung cancer and the need for consolidative radiation, as well as the optimal sequence of therapy for a patient with non–small cell lung cancer who harbors a MET exon 14 mutation.